Spots Global Cancer Trial Database for Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Official Title: Three Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Study
Study ID: NCT05080010
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.
Detailed Description: This study will be a phase Ⅲ open label interventional case series. Patients with Stage I enucleated retinoblastoma will receive 3 cycles of chemotherapy(CEV) oon a monthly basis. Patients will be followed for 60 months.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact Details
Name: Huasheng Yang, M.D, PHD
Affiliation: Zhongshan Ophthalmic Center, Sun Yat-sen University
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
